Cendrine Cabou

1.2k total citations
28 papers, 978 citations indexed

About

Cendrine Cabou is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Cendrine Cabou has authored 28 papers receiving a total of 978 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 9 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Molecular Biology. Recurrent topics in Cendrine Cabou's work include Diabetes Treatment and Management (7 papers), Adenosine and Purinergic Signaling (6 papers) and Regulation of Appetite and Obesity (5 papers). Cendrine Cabou is often cited by papers focused on Diabetes Treatment and Management (7 papers), Adenosine and Purinergic Signaling (6 papers) and Regulation of Appetite and Obesity (5 papers). Cendrine Cabou collaborates with scholars based in France, United Kingdom and Canada. Cendrine Cabou's co-authors include Rémy Burcelin, Rémy Burcelin, Bernard Payrastre, Marie‐Pierre Gratacap, Daniel J. Drucker, Laurent O. Martinez, Bart Vanhaesebroeck, G. Campistron, Gaëtan Chicanne and Chr̀istophe Magnan and has published in prestigious journals such as Blood, Diabetes and International Journal of Molecular Sciences.

In The Last Decade

Cendrine Cabou

27 papers receiving 970 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cendrine Cabou France 17 373 343 301 160 146 28 978
Stefan Amisten Sweden 26 499 1.3× 780 2.3× 773 2.6× 197 1.2× 123 0.8× 44 1.7k
Ann‐Cathrine Jönsson‐Rylander Sweden 14 177 0.5× 357 1.0× 251 0.8× 74 0.5× 26 0.2× 26 911
Illiana Meurs Netherlands 21 321 0.9× 601 1.8× 911 3.0× 182 1.1× 46 0.3× 31 1.6k
Roberto Catalán Spain 16 402 1.1× 123 0.4× 126 0.4× 131 0.8× 34 0.2× 22 998
Toru Sugiyama Japan 20 402 1.1× 303 0.9× 338 1.1× 196 1.2× 16 0.1× 46 1.2k
Hisko Oeseburg Netherlands 9 149 0.4× 298 0.9× 101 0.3× 299 1.9× 154 1.1× 12 899
Rita P. S. Middelberg Australia 12 167 0.4× 251 0.7× 150 0.5× 139 0.9× 153 1.0× 18 797
S Mori Japan 11 183 0.5× 282 0.8× 239 0.8× 301 1.9× 22 0.2× 21 903
A. Bobik Australia 20 269 0.7× 461 1.3× 140 0.5× 237 1.5× 37 0.3× 39 1.5k
Alessio Metere Italy 17 144 0.4× 216 0.6× 147 0.5× 129 0.8× 43 0.3× 34 734

Countries citing papers authored by Cendrine Cabou

Since Specialization
Citations

This map shows the geographic impact of Cendrine Cabou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cendrine Cabou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cendrine Cabou more than expected).

Fields of papers citing papers by Cendrine Cabou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cendrine Cabou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cendrine Cabou. The network helps show where Cendrine Cabou may publish in the future.

Co-authorship network of co-authors of Cendrine Cabou

This figure shows the co-authorship network connecting the top 25 collaborators of Cendrine Cabou. A scholar is included among the top collaborators of Cendrine Cabou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cendrine Cabou. Cendrine Cabou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Torossian, Alexander, Annelise Genoux, Mikaël Croyal, et al.. (2025). Plasma apolipoprotein concentrations and occurrence of cardiovascular events in the general population: an exploratory analysis. PubMed. 60. 35–42. 1 indexed citations
2.
Duparc, Thibaut, Guillaume Combes, Diane Beuzelin, et al.. (2024). P2Y13 receptor deficiency favors adipose tissue lipolysis and worsens insulin resistance and fatty liver disease. JCI Insight. 9(8).
3.
Garcia, Cédric, Thomas Édouard, Sophie Voisin, et al.. (2019). Catalytic dysregulation of SHP2 leading to Noonan syndromes affects platelet signaling and functions. Blood. 134(25). 2304–2317. 20 indexed citations
4.
Cabou, Cendrine, Thibaut Duparc, Guillaume Combes, et al.. (2019). Pharmacological inhibition of the F1‐ATPase/P2Y1 pathway suppresses the effect of apolipoprotein A1 on endothelial nitric oxide synthesis and vasorelaxation. Acta Physiologica. 226(3). e13268–e13268. 15 indexed citations
5.
Valera, Marie‐Cécile, Emmanuelle Noirrit‐Esclassan, Marion Dupuis, et al.. (2018). Effect of estetrol, a selective nuclear estrogen receptor modulator, in mouse models of arterial and venous thrombosis. Molecular and Cellular Endocrinology. 477. 132–139. 28 indexed citations
6.
Laurent, Pierre, Béatrice Hechler, Romain Solinhac, et al.. (2018). Impact of PI3Kα (Phosphoinositide 3-Kinase Alpha) Inhibition on Hemostasis and Thrombosis. Arteriosclerosis Thrombosis and Vascular Biology. 38(9). 2041–2053. 24 indexed citations
7.
Malet, Nicole, Claudia Radojkovic, Cendrine Cabou, et al.. (2017). PI3Kβ Plays a Key Role in Apolipoprotein A-I-Induced Endothelial Cell Proliferation Through Activation of the Ecto-F1-ATPase/P2Y1 Receptors. Cellular Physiology and Biochemistry. 42(2). 579–593. 23 indexed citations
8.
Valet, Colin, M Levade, Gaëtan Chicanne, et al.. (2017). A dual role for the class III PI3K, Vps34, in platelet production and thrombus growth. Blood. 130(18). 2032–2042. 35 indexed citations
9.
Valet, Colin, Gaëtan Chicanne, Childérick Séverac, et al.. (2015). Essential role of class II PI3K-C2α in platelet membrane morphology. Blood. 126(9). 1128–1137. 47 indexed citations
10.
Martinez, Laurent O., Souad Najib, Bertrand Perret, Cendrine Cabou, & Laeticia Lichtenstein. (2014). Ecto-F1-ATPase/P2Y pathways in metabolic and vascular functions of high density lipoproteins. Atherosclerosis. 238(1). 89–100. 42 indexed citations
11.
Serhan, Nizar, Cendrine Cabou, Laeticia Lichtenstein, et al.. (2012). Chronic pharmacological activation of P2Y13 receptor in mice decreases HDL-cholesterol level by increasing hepatic HDL uptake and bile acid secretion. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1831(4). 719–725. 29 indexed citations
12.
Valera, Marie‐Cécile, Marie‐Pierre Gratacap, Pierre Gourdy, et al.. (2012). Chronic estradiol treatment reduces platelet responses and protects mice from thromboembolism through the hematopoietic estrogen receptor α. Blood. 120(8). 1703–1712. 50 indexed citations
13.
Martinez, Laurent O., Cendrine Cabou, Véronique Pons, & Camille Malaval. (2012). P2Y receptors in atherosclerosis: from lipid metabolism to vascular functions. 1(6). 743–754. 5 indexed citations
14.
Cabou, Cendrine & Rémy Burcelin. (2011). GLP-1, the Gut-Brain, and Brain-Periphery Axes. The Review of Diabetic Studies. 8(3). 418–431. 85 indexed citations
15.
Burcelin, Rémy, Matteo Sérino, & Cendrine Cabou. (2009). A role for the gut-to-brain GLP-1-dependent axis in the control of metabolism. Current Opinion in Pharmacology. 9(6). 744–752. 35 indexed citations
16.
Cabou, Cendrine, G. Campistron, Corinne Leloup, et al.. (2008). Brain Glucagon-Like Peptide-1 Regulates Arterial Blood Flow, Heart Rate, and Insulin Sensitivity. Diabetes. 57(10). 2577–2587. 98 indexed citations
17.
Knauf, Claude, Patrice D. Cani, Afifa Ait-Belgnaoui, et al.. (2008). Brain Glucagon-Like Peptide 1 Signaling Controls the Onset of High-Fat Diet-Induced Insulin Resistance and Reduces Energy Expenditure. Endocrinology. 149(10). 4768–4777. 84 indexed citations
18.
Lacroix, Isabelle, Cendrine Cabou, Jean‐Louis Montastruc, & Christine Damase‐Michel. (2007). Effets indésirables des médicaments chez la femme enceinte. Therapies. 62(5). 455–460. 6 indexed citations
19.
Cabou, Cendrine, Isabelle Lacroix, Jérôme Roncalli, et al.. (2006). [Myocardial infarction in a young female smoker taking oral contraception].. PubMed. 99(1). 80–5. 3 indexed citations
20.
Cabou, Cendrine, Haleh Bagheri, A. Cantagrel, Bernard Mazières, & Jean‐Louis Montastruc. (2003). Analyse rétrospective des effets indésirables de l’infliximab dans un service hospitalier de rhumatologie. Therapies. 58(5). 457–462. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefan Amisten Breakdown of academic impact, for papers by Ann‐Cathrine Jönsson‐Rylander Breakdown of academic impact, for papers by Illiana Meurs Breakdown of academic impact, for papers by Roberto Catalán Breakdown of academic impact, for papers by Toru Sugiyama Breakdown of academic impact, for papers by Hisko Oeseburg Breakdown of academic impact, for papers by Rita P. S. Middelberg Breakdown of academic impact, for papers by S Mori Breakdown of academic impact, for papers by A. Bobik Breakdown of academic impact, for papers by Alessio Metere
Rankless by CCL
2026